DOCUMENTS

SAVAC 2nd Stakeholders meeting Report 06JUNE2022
  • SAVAC 2nd Stakeholders meeting Report 06JUNE2022.pdfDownload
Presentation slides at the second SAVAC Stakeholders Meeting, 06 June 2022
  • 1. A strategic approach to understand strep A disease burden_Jonathan Carapetis.pdfDownload
  • 2. Immunologic protection and correlates_Shiranee Sriskandan.pdfDownload
  • 3. Strep A Vaccine Safety Considerations and Guidance during Development_Edwin Asturias.pdfDownload
  • 4. Potential impact of prospective strep A vaccines on the global burden of disease_model based analysis_Kaja Abbas.pdfDownload
  • 5. Global economic burden for Strep A infections and cost effectiveness analysis for a hypothetical Strep A vaccine_Jung Seok Lee.pdfDownload
  • 6. The full health economic social benefits of vaccination_conceptual framework and application to Strep A vaccines_Dan Cadarette.pdfDownload
  • 7. The Effect of a Prospective Vaccine Against Group A Streptococcus on Global Antibiotic Consumption for Sore Throat_Jeff Cannon.pdfDownload
  • 8. Global health and economic benefits _Maddalena Ferranna.pdfDownload
  • 9. Business Case for Industry Investment in Strep A Vaccine R&D_Don Walkinshaw.pdfDownload
  • 10. Optimal Global Spending for Group A Streptococcus Vaccine Research and Development_Dan Tortorice.pdfDownload
SAVAC Stakeholders meeting Report 13JUNE2021
  • SAVAC Stakeholders meeting Report 13JUNE2021.pdfDownload
SAVAC High Level Development Strategy 8MAY2020
  • SAVAC High Level Development Strategy 8MAY2020.pdfDownload
Vekemans WHO GAS vaccine R&D roadmap CID 2019
  • Vekemans WHO GAS vaccine R&D roadmap CID 2019.pdfDownload
WHO-IVB-18.07-WHO Preferred Product Characteristics for GAS Vaccines 2018
  • WHO-IVB-18.07-WHO Preferred Product Characteristics for GAS Vaccines 2018.pdfDownload
WHO-IVB-18.08-GAS Vaccine Develoment Technology Roadmap 2018
  • WHO-IVB-18.08-GAS Vaccine Develoment Technology Roadmap 2018.pdfDownload